Uveitis in Patients with Retinitis Pigmentosa: 30 Years' Consecutive Data

Ocul Immunol Inflamm. 2018;26(8):1283-1288. doi: 10.1080/09273948.2017.1348527. Epub 2017 Sep 29.

Abstract

Purpose: To describe the clinical pattern of uveitis in patients with retinitis pigmentosa (RP) at a tertiary care eye hospital over a period of 30 years.

Methods: The medical records of 32 eyes of 22 patients of RP with uveitis were included in this study. Collected data included age, subsets of uveitis, best corrected visual acuities (BCVA), detailed laboratory investigations, and treatment.

Results: Mean age at presentation was 53.4 ± 18.8 years, and mean age of diagnosis of RP was 39.2 ± 21.4 years. Uveitis was bilateral in 10 (45.5%) patients. The most common of uveitis in current study was anterior uveitis (56.2%), followed by intermediate uveitis (43.8%). Cataract developed in 12 (37.5%) eyes, and three eyes had raised intraocular pressure. Ten patients (45.5%) required oral steroid, and one patient required oral methotrexate.

Conclusions: Uveitis in RP patients is rare, but not uncommon. Coexistence of these disorders might support the inflammatory pathway in etiology of RP.

Keywords: Cystoid macular edema; Fuch’s uveitis; intermediate uveitis; retinitis pigmentosa; uveitis.

MeSH terms

  • Adult
  • Aged
  • Electroretinography
  • Female
  • Fluorescein Angiography
  • Glucocorticoids / therapeutic use
  • Humans
  • Immunosuppressive Agents / therapeutic use
  • Male
  • Methotrexate / therapeutic use
  • Middle Aged
  • Retinitis Pigmentosa / complications*
  • Retinitis Pigmentosa / diagnosis
  • Retinitis Pigmentosa / drug therapy
  • Retrospective Studies
  • Tertiary Care Centers
  • Uveitis / complications*
  • Uveitis / diagnosis
  • Uveitis / drug therapy
  • Visual Acuity

Substances

  • Glucocorticoids
  • Immunosuppressive Agents
  • Methotrexate